216 Appendix 67. R. Slot: Subjective cognitive decline-predictive value of biomarkers in the context of preclinical Alzheimer’s disease (14-11-2019) 68. N. Scheltens: Understanding heterogeneity in Alzheimer’s disease-a data driven approach (17-12-2019) 69. L. Vermunt: Secondary Prevention for Alzheimer Disease – Timing, Selection and Endpoint of Clinical Trials (13-03-2020) 70. L.M.P. Wesselman: Lifestyle and brain health – exploring possibilities of an online intervention in non-demented elderly (01-04-2020) 71. I.S. van Maurik: Interpreting biomarker results in patients with mild cognitive impairment to estimate prognosis and optimize decision making (12-05-2020) (Cum Laude) 72. E. Dicks: Grey matter covariance networks in Alzheimer’s disease: Edging towards a better understanding of disease progression (09-09-2020) 73. J.J. van der Zande: A sharper image of dementia with Lewy bodies: the role of imaging and neurophysiology in DLB, and the influence of concomitant Alzheimer’s disease pathology (21-09-2020) 74. I. van Steenoven: Cerebrospinal fluid biomarkers in dementia with Lewy bodies – towards a biological diagnosis (22-09-2020) 75. N. Beker: Cognition in Centenarians – evaluation of cognitive health and underlying factors in centenarians from the 100-plus Study (02-10-2020) 76. F. A. de Leeuw: Nutrition and metabolic profiles in Alzheimer’s disease (03-12-2020) 77. T. Timmers: Tau PET across the Alzheimer’s disease continuum (02-12-2020) 78. E.E. Wolters: Untangling tau pathology using PET (02-12-2020) 79. A.S. Doorduijn: Nutrition, the unrecognized determinant in Alzheimer’s disease (12-01-2021) 80. A. de Wilde: Visualizing Brain Amyloid-beta Pathology (17-03-2021) 81. C. Groot: Heterogeneity in Alzheimer’s Disease (06-04-2021) 82. D. Bertens: The use of biomarkers in non-demented AD patients for clinical trial design and clinical practice (14-04-2021) 83. J. Reimand: Discordance between amyloid-PET and CSF biomarkers: Clinical and pathophysiological consequences (12-05-2021) 84. L.E. Collij: The AMYPAD project: Towards the next stage in amyloid PET imaging (01-07-2021) 85. C.T. Briels: Evaluation and implementation of functional cerebral biomarkers in Alzheimer’s disease (15-05-2021) 86. N. Tesi: The Genetics of Cognitively Healthy Centenarians (28-09-2021)
RkJQdWJsaXNoZXIy MjY0ODMw